EBITDA pre exceptionals for the fourth quarter significantly above market expectation
|
EQS-Ad-hoc: LANXESS Aktiengesellschaft / Key word(s): Preliminary Results/Quarter Results Ad hoc according to Art. 17 paragraph 1 MMVO LANXESS: EBITDA pre exceptionals for the fourth quarter significantly above market expectation
Specialty chemicals company LANXESS expects to have achieved about EUR 159 million EBITDA pre exceptionals for the fourth quarter 2024. This significantly exceeds market expectation of currently EUR 130 million (VARA consensus) by 22 percent. EBITDA pre exceptionals for the full year 2024 is therefore expected to amount to around EUR 614 million, approximately 20 percent above prior year’s level and at the upper end of the previously guided range of 10-20% growth. The fourth quarter was positively influenced by a stronger than expected December, in particular due to customers’ pre-buying. This pull-forward effect occurred mainly in the U.S. for products of the segments Specialty Additives and Consumer Protection. The underlying macroeconomic environment going into 2025 has however not improved. The fiscal year 2024 will end with around EUR 2.4 billion net financial debt compared to EUR 2.5 billion at the end of 2023. LANXESS will release its final results for the fourth quarter 2024 and the fiscal year 2024 on March 20, 2025. All figures provided in this release are preliminary and unaudited. Cologne, 20 January 2025 Forward-Looking Statements This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document. Contact: André Simon LANXESS AG Head of Investor Relations Kennedyplatz 1 50569 Köln, Deutschland Phone: +49 175 30 23494 E-Mail: andre.simon@lanxess.com End of Inside Information
20-Jan-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | LANXESS Aktiengesellschaft |
| Kennedyplatz 1 | |
| 50569 Cologne | |
| Germany | |
| Phone: | +49 (0)221 8885-9834 |
| Fax: | +49 (0)221 8885-4944 |
| E-mail: | ir@lanxess.com |
| Internet: | www.lanxess.com |
| ISIN: | DE0005470405 |
| WKN: | 547040 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2070991 |
| End of Announcement | EQS News Service |
|
|
2070991 20-Jan-2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.